Carl Zeiss Meditec: Goldman Sachs lifts voting rights stake to 5.02% from 4.83%

Goldman Sachs raised its total voting rights stake in Carl Zeiss Meditec to 5.02% from 4.83%, with holdings via instruments up to 4.48% from 4.26%. Voting rights tied to shares edged down to 0.54% from 0.57%; threshold crossing date was Sept. 23, 2026.